Back
Galmed Pharmaceuticals Vs. BioLine Rx Industry Stock Comparison
Sell
7
GLMD
Galmed Pharmaceuticals
Last Price:
2.90
Seasonality Move:
13.88%
Sell
49
BLRX
BioLine Rx
Last Price:
0.48
Seasonality Move:
-0.3%
Sell
7
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy, Sell or Hold?
- The current Galmed Pharmaceuticals [GLMD] share price is $2.93. The Score for GLMD is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- GLMD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.48. The Score for BLRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLMD Stock Price Chart
What is Galmed Pharmaceuticals's stock price today?
-
The Galmed Pharmaceuticals share price today is $2.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLMD is experiencing selling pressure, which indicates risk of future bearish movement.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.48
The current trend is relatively stagnant and BLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.43 | Sell |
Relative Strength Index (14 RSI): | 39.04 | Sell |
Chaikin Money Flow: | -19608 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.01 - 4.09) | Sell |
Bollinger Bands (100): | (2.42 - 5.86) | Sell |
BLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 53.61 | Buy |
Chaikin Money Flow: | 227756 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.42 - 0.46) | Buy |
Bollinger Bands (100): | (0.48 - 0.74) | Sell |
GLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3 | Sell |
20-day SMA: | 3.51 | Sell |
50-day SMA: | 4.72 | Sell |
200-day SMA: | 4.26 | Sell |
8-day EMA: | 3.07 | Sell |
20-day EMA: | 3.43 | Sell |
50-day EMA: | 3.99 | Sell |
200-day EMA: | 7.08 | Sell |
BLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.45 | Buy |
20-day SMA: | 0.44 | Buy |
50-day SMA: | 0.51 | Sell |
200-day SMA: | 0.74 | Sell |
8-day EMA: | 0.45 | Buy |
20-day EMA: | 0.45 | Buy |
50-day EMA: | 0.51 | Sell |
200-day EMA: | 0.75 | Sell |
Galmed Pharmaceuticals Earnings Growth & GLMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
Galmed Pharmaceuticals Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioLine Rx Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |